Integrated BioTherapeutics (United States)
- World rank, 2022–2025
- #17,284 of 28,054 · #20,932 all time
- Rank in United States
- #2,478 of 4,192
- Research works
- 239 ▲ 104% vs 2013–17
- Citations
- 4.4k 18.4 per fractional work
- Top-10% rate
- 10.7% record average 16.5%
- Open access
- 44% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 19.7×. Every wedge is a field page.
- Immunology and Microbiology 19.7×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Medicine 2.5×
- Neuroscience 1.2×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Veterinary 0.6×
- Engineering 0.3×
- Energy 0.3×
- Nursing 0.2×
- Chemistry 0.2×
- Health Professions 0.2×
- Mathematics 0.2×
- Materials Science 0.2×
- Economics, Econometrics and Finance 0.1×
- Computer Science 0.1×
- Environmental Science 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Integrated BioTherapeutics (United States)?
Ranked on the composite score, R. K. Oldham and Alexander Kamb lead among researchers whose main affiliation is Integrated BioTherapeutics (United States).
- 1 R. K. Oldham United States · #412,241 worldwide 107 citations · 22 works
- 2 Alexander Kamb United States · #479,194 worldwide 71 citations · 20 works
Which keywords describe research at Integrated BioTherapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, Leukemia, CAR T Cells, Chimeric Antigen Receptor and Glycosylation.
- Staphylococcus aureus
- Mutational Signatures
- Cancer Genomics
- Bacterial Therapy
- Angiogenesis
- Pathogenesis
- PET Imaging
- Tumor Targeting
- PD-1 and PD-L1
- Gene Therapy
- NK Cell Recognition
- Epidemiology
- Dendritic Cells
- Tumor Microenvironment
- Fc Receptors
- Monoclonal Antibodies
- Glycosylation
- CAR T Cells
- Lymphoma
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- Leukemia
- Chimeric Antigen Receptor
- Innate Immunity
- Immunity
- Therapeutic Antibodies
- Antigen Presentation
- Tumor Antigen
- Targeted Therapy
- Natural Killer Cells
- Immune Checkpoint Blockade
- Cancer
- Clinical Trials
- Cancer Therapy
- TGF-ß
- Arginine Deprivation
- CD4+CD25+
- Foxp3
- Atomic Layer Deposition
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy13▲ 117×3 topics
- Immunotherapy12▲ 23×10 topics
- Tumor Regression10▲ 122×2 topics
- Lymphoma8▲ 74×3 topics
- Leukemia8▲ 139×2 topics
- CAR T Cells8▲ 153×1 topic
- Chimeric Antigen Receptor8▲ 153×1 topic
- Glycosylation7▲ 84×3 topics
- Innate Immunity6▲ 29×6 topics
- Monoclonal Antibodies6▲ 98×2 topics
- Immunity6▲ 20×5 topics
- Fc Receptors6▲ 145×1 topic
- Therapeutic Antibodies6▲ 114×1 topic
- Tumor Microenvironment6▲ 18×8 topics
- Antigen Presentation5▲ 81×2 topics
- Dendritic Cells5▲ 74×1 topic
- Tumor Antigen5▲ 108×1 topic
- Epidemiology5▲ 1.63×21 topics
- Targeted Therapy4▲ 25×5 topics
- NK Cell Recognition4▲ 80×1 topic
- Natural Killer Cells4▲ 80×1 topic
- Gene Therapy4▲ 28×3 topics
- Immune Checkpoint Blockade3▲ 33×1 topic
- PD-1 and PD-L13▲ 33×1 topic
- Cancer2▲ 2.5×12 topics
- Tumor Targeting2▲ 18×3 topics
- Clinical Trials2▲ 4.4×6 topics
- PET Imaging2▲ 18×3 topics
- Cancer Therapy2▲ 5.1×8 topics
- Pathogenesis2▲ 5.0×8 topics
- TGF-ß2▲ 16×3 topics
- Angiogenesis2▲ 6.6×4 topics
- Arginine Deprivation2▲ 59×1 topic
- Bacterial Therapy2▲ 59×1 topic
- CD4+CD25+1▲ 58×1 topic
- Cancer Genomics1▲ 26×1 topic
- Foxp31▲ 58×1 topic
- Mutational Signatures1▲ 26×1 topic
- Atomic Layer Deposition1▲ 27×1 topic
- Staphylococcus aureus1▲ 25×2 topics
Which research topics does Integrated BioTherapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 8 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
- 3 Immunotherapy and Immune Responses Immunology 5 works
- 4 Immune Cell Function and Interaction Immunology 4 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 6 Cancer Research and Treatments Biotechnology 2 works
- 7 T-cell and B-cell Immunology Immunology 1 works
- 8 Virus-based gene therapy research Genetics 1 works
- 9 Cancer Genomics and Diagnostics Cancer Research 1 works
- 10 Semiconductor materials and devices Electrical and Electronic Engineering 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Integrated BioTherapeutics (United States)'s research output changed?
Output in 2018–2022 was 104% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- NIST Center for Neutron Research
- Material Measurement Laboratory
- Center for Nanoscale Science and Technology
- Information Technology Laboratory
- Robotic Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.